Prescribing Information for Gardasi|®9 (Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)): United Kingdom

By clicking the link above, you will leave this page and be taken to the EMC PI portal website.

These modules have been developed and fully funded by Merck Sharp & Dohme (MSD) as promotional modules for presentation to UK healthcare professionals. MSD manufactures GARDASIL®9 (Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed))¹

MSD in the UK does not recommend use of products outside their licensed indications. Please consult the Summary of Product Characteristics (SmPC) before prescribing or delivering the product.

Adverse events should be reported.

Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to MSD (Tel: 020 8154 8000).

GB-GSL-00825 Date of preparation October 2025